Belgium· BE-AMP-SAM246574-00
Tracleer 62.5 mg
A bosentan product containing bosentan monohydrate, registered in Belgium by Janssen-Cilag International. The same ATC class is registered in 18 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Bosentan is registered in 18 of 19 countries.
Countries holding a registration under ATC C02KX01 (bosentan), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 11 of them publish a price we can compare per daily dose
Bosentan · ATC C02KX01
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of bosentan costs, country by country.
Normalised to the WHO defined daily dose (0.25 g), the median price runs from $25.92 in Italy to $66.51 in Switzerland — a ×2.6 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Bosentan · price per daily dose (0.25 g)
USD · FX 28 Sept 2026
- CH Switzerland$66.51
- IT Italy$25.92
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Bosentan Monohydrate
- Manufacturer
- Janssen-Cilag International
- Country
- Belgium (BE)
- ATC code
- C02KX01
- ATC class
- Bosentan
- Defined daily dose
- 0.25 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0775825
- be_apb2071223
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
355 interactions on record for bosentan.
Graded by severity as the source publishes them — 45 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bosentan · interactions on record
355 records
- 45 severe
- 227 moderate
- 7 minor
- 69 info
Most severe, free to view
- GlibenclamideA10BB01severe
- Levonorgestrel and ethinylestradiolG03AA07severe
- Desogestrel and ethinylestradiolG03AA09severe
- Drospirenone and ethinylestradiolG03AA12severe
7 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bosentan in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainBOSENTAN ACCORDPHARMA 62,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- CzechiaBOSENTAN ABDIAbdi Farma GmbH, Heppenheim
- FinlandBosentan AccordAccord Healthcare B.V.
- NetherlandsBosentan ABDI 62,5 mg, filmomhulde tablettenAbdi Farma GmbH
- ItalyBOSENTAN ABDIABDI FARMA GMBH
- SwedenBosentan Accord 62,5 mg Filmdragerad tablettAccord Healthcare B.V.
- IrelandBosentan Accord 62.5 mg film-coated tabletsAccord Healthcare Ireland Ltd.
- FranceBOSENTAN ACCORD 62,5 mg, comprimé pelliculéACCORD HEALTHCARE FRANCE
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Bosentan Accord, Bosentan Reddy
- Bulgaria · Bosentan Sdz, Бозентан Акорд
- Cyprus · Bactoced, Bosentan Accord
- Czechia · Bosentan Abdi, Bosentan Accord
- Germany · Bosentan 1 A Pharma, Bosentan Accord
- Denmark · Bosentan Accord, Bosentan Cipla
- Estonia · Bosentan Accord, Bosentan Norameda
- Spain · Bosentan Accordpharma, Bosentán Accordpharma
- Finland · Bosentan Accord
- France · Bosentan Accord, Bosentan Arrow
- United Kingdom (Northern Ireland) · Bosentan Accord, Bosentan Generics [uk]
- Greece · Bocleer, Klimurtan
- Croatia · Bosentan Cipla, Bosentan Makpharm
- Hungary · Bosentan Pharmascience
- Ireland · Bosentan Accord, Bosentan Zentiva
- Iceland · Stayveer, Tracleer
- Italy · Bosentan Abdi, Bosentan Accord
- Liechtenstein · Stayveer, Tracleer
- Lithuania · Bosentan Accord, Bosentan Norameda
- Latvia · Bosentan Accord, Bosentan Norameda
- Malta · Bosentan Aurobindo
- Netherlands · Bosentan Abdi, Bosentan Accord
- Norway · Bosentan Accord, Bosentan Cipla
- Poland · Bopaho, Bosentan Accord
- Portugal · Bosentano Accord, Bosentano Aurobindo
- Romania · Bopaho, Bosentan Accord
- Sweden · Bosentan Accord, Bosentan Sandoz
- Slovenia · Bosentan Norameda
- Slovakia · Bosentan Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e9531d76-79dc-49a2-b1e1-c21641df83a2 GET /v1/drugs/e9531d76-79dc-49a2-b1e1-c21641df83a2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Tracleer 62.5 mg",
"name_fr": "Tracleer 62.5 mg",
"name_nl": "Tracleer 62.5 mg",
"amp_code": "SAM246574-00",
"strengths": [
"62.5000",
"62.5000"
],
"pack_count": 4,
"substances": [
"Bosentan Monohydrate",
"Bosentan",
"Sodium Starch Glycolate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Bosentan",
"authorisation_numbers": [
"EU/1/02/220/001",
"EU/1/02/220/002",
"EU/1/02/220/003",
"EU/1/02/220/007"
]
}See everything about bosentan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.